Form 8-K

8-K — Change Agents Corporation.

Accession: 0001213900-26-110727

Filed: 2026-10-19

Period: 2026-10-13

CIK: 0001630212

SIC: 7371 (SERVICES-COMPUTER PROGRAMMING SERVICES)

Item: Entry into a Material Definitive Agreement

Item: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Item: Unregistered Sales of Equity Securities

Item: Financial Statements and Exhibits

Documents

8-K — ea0308737-8k_change.htm (Primary)

EX-4.1 — FORM OF WAIVER PRE-FUNDED WARRANT (ea030873701ex4-1.htm)

EX-4.2 — FORM OF UNSECURED PROMISSORY NOTE (ea030873701ex4-2.htm)

EX-10.1 — FORM OF OCTOBER 2026 WAIVER (ea030873701ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0308737-8k_change.htm · Sequence: 1

false

0001630212

2026-10-13

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

October 13, 2026

Change Agents Corporation

(Exact name of registrant as specified in its charter)

Delaware

001-38728

47-1685128

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I. R. S. Employer

Identification No.)

4400 Route 9 South, Suite 3100

Freehold, NJ 07728

(Address of principal executive offices, including

ZIP code)

(732) 780-4400

(Registrant’s telephone number, including

area code)

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.0001 par value

CHGA

The Nasdaq Capital Market

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

1.01 Entry into a Material Definitive Agreement.

Waivers

and Pre-Funded Warrants

October 14, 2026, Change Agents Corporation (the “Company”) entered into certain waivers (the “October 2026 Waivers”)

with each of Dune Equity Holdings, LLC (“Dune”) and FirstFire Global Opportunities Fund, LLC (“Firstfire”) to

waive their prepayment provisions with respect to a recent note issuance and recent sale of shares under an equity purchase agreement.

In consideration of the October 2026 Waivers, the Company issued pre-funded warrants to each of Dune and FirstFire (collectively, the

“Waiver Pre-Funded Warrants”) to purchase 62,000 and 37,500 shares of common stock, par value $0.0001 per share (“Common Stock”), respectively (collectively, the “Waiver

Pre-Funded Warrant Shares). The Waiver Pre-Funded Warrants are immediately exercisable and may be exercised at a nominal exercise price

of $0.0001 per share of Common Stock at any time until all of the Waiver Pre-Funded Warrants are exercised in full; provided, however,

that until the Company has obtained stockholder approval for issuance of the Waiver Pre-Funded Warrant Shares, the Company shall not

issue a number of Waiver Pre-Funded Warrant Shares, which when aggregated with all other securities that are required to be aggregated

for purposes of Nasdaq Listing Rule 5635(d), would exceed 19.99% of the shares of Common Stock outstanding as of the date of definitive

agreement with respect to the first of such aggregated transactions A holder may not exercise any portion of the Waiver Pre-Funded Warrants

to the extent the Purchaser would own more than 4.99% of the outstanding Common Stock immediately after exercise. A holder may increase

or decrease this percentage with respect to Waiver Pre-Funded Warrants to a percentage not in excess of 9.99%, except that any such increase

shall require at least 61 days’ prior notice to the Company. In addition, the Company shall not issue a number of Common Stock

pursuant to the exercise of this Warrant, which when aggregated with all other securities that are required to be aggregated for purposes

of Nasdaq Listing Rule 5635(d), would exceed 19.99% of the shares of Common Stock outstanding as of the date of definitive agreement

with respect to the first of such aggregated transactions, unless the Company has obtained the Stockholder Approval The Waiver Pre-Funded

Warrants also provide that if the Company fails to procure stockholder approval for issuance of the Waiver Pre-Funded Warrant Shares

on or before the date which is 90-days after issuance of the Waiver Pre-Funded Warrants, then the holders of such warrants will have

the right to require the Company to pay a buyout fee redeem the warrants in the amount of $150,000 for Dune and $75,000 for FirstFire

unless this Pre-Funded Warrants are exercisable in full on the Stockholder Approval Deadline Date in accordance with Nasdaq Listing Rule

5635(d), in which case no buyout amount shall be due and payable. The October 2026 Waivers also granted piggyback registration rights.

The

foregoing description of each of the October 2026 Waivers and the Waiver Pre-Funded Warrants does not purport to be complete and is qualified

in its entirety by reference to the full text of the October 2026 Waivers and the Waiver Pre-Funded Warrants , copies of which are filed

as Exhibits 10.1 and 4.1 to this Current Report on Form 8-K and are incorporated herein by reference.

Unsecured

Promissory Notes

On October 16, 2026, the Company

executed unsecured promissory notes (the “Unsecured Promissory Notes”) in the amounts of $150,000 and $100,000 with amounts

due at maturity on December 1, 2026 of $183,335.00 and $116,665.00, respectively.

The foregoing description

of the unsecured promissory notes does not purport to be complete and is qualified in its entirety by reference to the full text of the

form of unsecured promissory note a copy of which is filed as Exhibit 4.2 to this Current Report on Form 8-K and incorporated herein by

reference.

Item 2.03 Creation

of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set

forth under Item 1.01 of this Current Report on Form 8-K relating to the Unsecured Promissory Notes is incorporated by reference into

this Item 2.03.

On October 13, 2026,

the Company’s Chief Strategy Officer (CSO), Luisa Ingargiola, advanced the Company $7,500 so that the Company would timely make

a loan payment under its Business Loan and Security Agreement with Agile Funding. The Company repaid this advance in October 2026.

Item

3.02 Unregistered Sales of Equity Securities.

of the date of this report, the Company has 1,254,947 shares of Common Stock outstanding.

The

information set forth under Item 1.01 of this Current Report on Form 8-K relating to the Waiver Pre-Funded Warrants and the Waiver Pre-Funded

Warrant Shares is incorporated by reference into this Item 3.02. The Waiver Pre-Funded Warrants and the Waiver Pre-Funded Warrant Shares

have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws

and were offered and sold, or will be issued, in reliance upon exemptions from the registration requirements of the Securities Act, including

Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws.

-1-

Item

9.01 Financial Statements and Exhibits.

(d)

Exhibits.

The

exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.

Exhibit

No.

Description

of Exhibit

4.1

Form of Waiver Pre-Funded Warrant

4.2

Form of Unsecured Promissory Note

10.1

Form of October 2026 Waiver

104#

Cover Page Interactive Data File (embedded within the

Inline XBRL document)

-2-

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Date: October 19, 2026

Change Agents Corporation

/s/ Sam Knipper

Sam Knipper

Chief Financial Officer

-3-

EX-4.1 — FORM OF WAIVER PRE-FUNDED WARRANT

EX-4.1

Filename: ea030873701ex4-1.htm · Sequence: 2

Exhibit

4.1

NEITHER

THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION

OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED

(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS

OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR

TO SUCH EFFECT. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE

MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

PRE-FUNDED

COMMON STOCK PURCHASE WARRANT

CHANGE

AGENTS CORPORATION

Warrant

Shares: [62,000[37,500]

Date

of Issuance: October 4, 2026 (“Issuance Date”)

This

COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [Dune Equity Holdings LLC][FirstFire

Global Opportunities Fund LLC}, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”),

is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after

the Issuance Date (the “Initial Exercise Date”), to purchase from CHANGE AGENTS CORPORATION, a Delaware corporation

(the “Company”), [62,000][37,500] shares of Common Stock (the “Warrant Shares”) (whereby such number

may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect.

This Warrant is issued by the Company to the Holder as of the Issuance Date, pursuant to the waiver agreement entered into on the Issuance

Date by and among the Company and the Holder (the “Waiver”).

Capitalized

terms used in this Warrant shall have the meanings set forth in the Waiver unless otherwise defined in the body of this Warrant or in

Section 16 below. For purposes of this Warrant, the term “Exercise Price” shall mean $0.0001, subject to adjustment as provided

herein (including but not limited to cashless exercise). “Exercise Period” shall mean the period commencing on the Initial

Exercise Date and ending on 5:00 p.m. eastern standard time on the date that is five (5) years after the Initial Exercise Date; provided,

however, that if (i) the Holder delivers the Buyout Notice (as defined in the Waiver) (the “Buyout Notice”) as set forth

in the Waiver and (ii) the Company pays the Buyout Amount (as defined in the Waiver) to the Holder in accordance with the terms of the

Waiver, then this Warrant shall be extinguished and redeemed in its entirety. Notwithstanding anything to the contrary in this Warrant,

upon the first occurrence of the Common Stock being deemed to be a “penny stock” as defined in SEC Rule 240.3a51-1 on or

after the Issuance Date (the “Trigger Date”), this Warrant shall no longer be exercisable into Common Stock as of the Trigger

Date.

EXERCISE OF WARRANT.

(a)

Mechanics of Exercise. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised in

whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as Exhibit

A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. The Holder shall not be required

to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant resulting in purchases of

a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant

Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. On or before the second Trading

Day (the “Warrant Share Delivery Date”) following the date on which the Holder sent the Exercise Notice to the Company

or the Company’s transfer agent, and upon receipt by the Company of payment to the Company of an amount equal to the applicable

Exercise Price multiplied by the number of Warrant Shares as to which all or a portion of this Warrant is being exercised (the “Aggregate

Exercise Price” and together with the Exercise Notice, the “Exercise Delivery Documents”) in cash or by

wire transfer of immediately available funds (or by cashless exercise, in which case there shall be no Aggregate Exercise Price provided),

the Company shall (or direct its transfer agent to) issue and deliver by overnight courier to the address as specified in the Exercise

Notice, a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of

shares of Common Stock to which the Holder is entitled pursuant to such exercise (or deliver such shares of Common Stock in electronic

format if requested by the Holder). Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes

to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the

date of delivery of the certificates evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and

the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired

upon an exercise, then the Company shall as soon as practicable and in no event later than three Business Days after any exercise and

at its own expense, issue a new Warrant (in accordance with Section 7) representing the right to purchase the number of Warrant Shares

purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant

is exercised.

the Company fails to cause its transfer agent to issue to the Holder the respective shares of Common Stock by the respective Warrant

Share Delivery Date, then the Holder will have the right to rescind such exercise in Holder’s sole discretion in addition to all

other rights and remedies at law, under this Warrant, or otherwise.

the Market Price of one share of Common Stock is greater than the Exercise Price, then the Holder may elect to receive Warrant Shares

pursuant to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below

(or of any portion thereof remaining unexercised) by delivery of an Exercise Notice, in which event the Company shall issue to Holder

a number of Common Stock computed using the following formula:

Y (A-B)

Where

X =

the

number of Shares to be issued to Holder.

the

number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date

of such calculation).

the

Market Price (at the date of such calculation).

Exercise

Price (as adjusted to the date of such calculation).

(b)

No Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment

pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining

whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance

of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction

a sum in cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.

(c)

Holder’s Exercise Limitations ; Exchange Cap. Notwithstanding anything to the contrary contained herein, the Company

shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant

to Section 1 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Exercise

Notice, the Holder (together with the Holder’s Affiliates), and any other Persons acting as a group together with the Holder or

any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial

Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned

by the Holder and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with

respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon

(i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution

Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including,

without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation

contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding

sentence, for purposes of this Section 1(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange

Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Holder is solely responsible for

any schedules required to be filed in accordance therewith. In addition, a determination as to any group status as contemplated above

shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes

of this Section 1(c), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding

shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the

case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company’s

transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company

shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any

case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities

of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number

of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of

shares of the Common Stock outstanding at the time of the respective calculation hereunder. Notwithstanding anything in this Warrant

to the contrary, the Company shall not issue a number of Common Stock pursuant to the exercise of this Warrant, which when aggregated

with all other securities that are required to be aggregated for purposes of Nasdaq Listing Rule 5635(d), would exceed 19.99% of the

shares of Common Stock outstanding as of the date of definitive agreement with respect to the first of such aggregated transactions,

unless the Company has obtained the Stockholder Approval (as defined in the Waiver) (the “Stockholder Approval”). If the

Company does not obtain Stockholder Approval at the first meeting of its shareholders after the Issuance Date, the Company shall call

a meeting every ninety (90) calendar days thereafter to seek Stockholder Approval until the earlier of the date on which Stockholder

Approval is obtained or this Warrant is no longer outstanding. If the Stockholder Approval is not obtained and deemed effective under

Delaware law on or before the date that is ninety (90) calendar days after the Issuance Date (the “Stockholder Approval Deadline

Date”), then the Holder shall have the right, exercisable upon written notice to the Company within seven (7) calendar days of

the Stockholder Approval Deadline Date (the “Buyout Notice”), to require the Company to pay [$150,000.00][$75,000] (the “Buyout

Amount”) in cash to the Holder within five (5) calendar days of the date of the Buyout Notice; unless this Warrant exercisable

in full on the Stockholder Approval Deadline Date in accordance with Nasdaq Listing Rule 5635(d), in which case no Buyout Amount shall

be due and payable. If (i) the Holder delivers the Buyout Notice pursuant to the immediately preceding sentence and (ii) the Company

pays the Buyout Amount to the Holder within five (5) calendar days of the date of the Buyout Notice, then this Warrant shall be extinguished

and redeemed in the entirety. If (i) the Stockholder Approval is obtained and deemed effective under Delaware law and (ii) the average

of the closing prices of the Common Stock on the Principal Market for the five (5) Trading Days immediately preceding the Stockholder

Approval Date (the “True-Up Price”) is less than $2.50 per share (subject to adjustment for any stock dividend, stock split,

stock combination, rights offerings, reclassification or similar transaction that proportionately decreases or increases the number of

outstanding Common Stock), then the Company shall pay True-Up Payment (as defined in this Warrant) to the Holder within three (3) Trading

Days of the Stockholder Approval Date. The “True-Up Payment” shall mean [$150,000.00][$75,000.00] minus the Warrants Value

(as defined in this Warrant). The “Warrants Value” shall mean the total number of Exercise Shares underlying the Warrants

on the Stockholder Approval Date multiplied by the True-Up Price. “Trading Day” shall mean a day on which the Principal Market

shall be open for business. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

(d)

Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to

the Holder, if the Company fails to cause the Company’s transfer agent to deliver to the Holder the Warrant Shares in accordance

with the provisions of this Warrant (including but not limited to Section 1(a) above pursuant to an exercise on or before the respective

Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or

otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the

Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall

(A) pay in cash to the Holder, within one (1) Business Day of Holder’s request, the amount, if any, by which (x) the Holder’s

total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the product of

(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times

(2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either

reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such

exercise shall be deemed rescinded) or deliver to the Holder within one (1) Business Day of Holder’s request the number of shares

of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For

example, if the Holder purchases, or effectuates a cashless exercise hereunder for, Common Stock having a total purchase price of $11,000

to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase

obligation of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000.

The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request

of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available

to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect

to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms

hereof.

ADJUSTMENTS. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment

from time to time as set forth in this Section 2.

(a)

Stock Dividends and Splits. Without limiting any provision of Section 4, if the Company, at any time on or after the Issuance

Date, (i) pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a distribution

on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any stock split, stock dividend, recapitalization

or otherwise) one or more classes of its then outstanding shares of Common Stock into a larger number of shares or (iii) combines (by

combination, reverse stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller number

of shares, then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of

shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common

Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately

after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant

to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.

If any event requiring an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then

the calculation of such Exercise Price shall be adjusted appropriately to reflect such event.

(b)

[Reserved].

PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.

(a)

[Reserved]

(b)

Fundamental Transactions. The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity

assumes in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 4(b)

pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder prior to such Fundamental

Transaction, including agreements to deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced

by a written instrument substantially similar in form and substance to this Warrant, including, without limitation, which is exercisable

for a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise

of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an

exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value

of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments

to the number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant

immediately prior to the consummation of such Fundamental Transaction). Upon the consummation of each Fundamental Transaction, the Successor

Entity shall succeed to, and be substituted for (so that from and after the date of the applicable Fundamental Transaction, the provisions

of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity),

and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the

other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation

of each Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise

of this Warrant at any time after the consummation of the applicable Fundamental Transaction, in lieu of the shares of Common Stock (or

other securities, cash, assets or other property issuable upon the exercise of this Warrant prior to the applicable Fundamental Transaction,

such shares of publicly traded common stock (or its equivalent) of the Successor Entity (including its Parent Entity) which the Holder

would have been entitled to receive upon the happening of the applicable Fundamental Transaction had this Warrant been exercised immediately

prior to the applicable Fundamental Transaction (without regard to any limitations on the exercise of this Warrant), as adjusted in accordance

with the provisions of this Warrant. Notwithstanding the foregoing, and without limiting Section 1(c) hereof, the Holder may elect, at

its sole option, by delivery of written notice to the Company to waive this Section 4(b) to permit the Fundamental Transaction without

the assumption of this Warrant. In addition to and not in substitution for any other rights hereunder, prior to the consummation of each

Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect

to or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to insure

that the Holder will thereafter have the right to receive upon an exercise of this Warrant at any time after the consummation of the

applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other securities,

cash, assets or other property issuable upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,

securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the Holder

would have been entitled to receive upon the happening of the applicable Fundamental Transaction had this Warrant been exercised immediately

prior to the applicable Fundamental Transaction (without regard to any limitations on the exercise of this Warrant) (the “Corporate

Event Consideration”). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory

to the Holder.

(c)

[Reserved]

(d)

Application. The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and

shall be applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without regard to any limitations on

the exercise of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Beneficial Ownership Limitation,

applied however with respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of this

Warrant (or any such other warrant)).

NON-CIRCUMVENTION. The Company covenants and agrees that it will not, by amendment of its articles of incorporation, bylaws or

through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,

or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at

all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of

the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common

Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be

necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock

upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved, free from

preemptive rights, two (2) times the number of shares of Common Stock into which the Warrants are then exercisable into to provide for

the exercise of the rights represented by this Warrant (without regard to any limitations on exercise).

WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in its capacity

as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company

for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder

of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action

(whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice

of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which

it is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed

as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder

of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6,

the Company shall provide the Holder with copies of the same notices and other information given to the stockholders of the Company generally,

contemporaneously with the giving thereof to the stockholders.

REISSUANCE.

(a)

Lost, Stolen or Mutilated Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as

to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),

issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.

(b)

Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such

new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which

is the same as the Issuance Date.

TRANSFER. This Warrant shall be binding upon the Company and its successors and assigns, and shall inure to be the benefit of

the Holder and its successors and assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations of the

Company hereunder may not be assigned, by operation of law or otherwise, in whole or in part, by the Company without the prior signed

written consent of the Holder, which consent may be withheld at the sole discretion of the Holder (any such assignment or transfer shall

be null and void if the Company does not obtain the prior signed written consent of the Holder). This Warrant or any of the severable

rights and obligations inuring to the benefit of or to be performed by Holder hereunder may be assigned by Holder to a third party, in

whole or in part, without the need to obtain the Company’s consent thereto.

NOTICES. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given

in accordance with the notice provisions contained in the Note (as defined in the Waiver). The Company shall provide the Holder with

prompt written notice (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation

of such adjustment and (ii) at least 20 days prior to the date on which the Company closes its books or takes a record (A) with respect

to any dividend or distribution upon the shares of Common Stock, (B) with respect to any grants, issuances or sales of any stock or other

securities directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock or other property, pro rata

to the holders of shares of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution

or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction with such notice

being provided to the Holder.

10.

DISCLOSURE. Upon delivery by the Company to the Holder (or receipt by the Company from the Holder) of any notice in accordance

with the terms of this Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute

material, non-public information relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York

city time on the Business Day immediately following such notice delivery date, publicly disclose such material, non-public information

on a Current Report on Form 8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information

relating to the Company or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice

(or immediately upon receipt of notice from the Holder, as applicable), and in the absence of any such written indication in such notice

(or notification from the Company immediately upon receipt of notice from the Holder), the Holder shall be entitled to presume that information

contained in the notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing

contained in this Section 10 shall limit any obligations of the Company, or any rights of the Holder, under the Waiver.

11.

ABSENCE OF TRADING AND DISCLOSURE RESTRICTIONS. The Company acknowledges and agrees that the Holder is not a fiduciary or agent

of the Company and that the Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company

or (b) refrain from trading any securities while in possession of such information in the absence of a written non-disclosure agreement

signed by an officer of the Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such

an executed, written non-disclosure agreement and subject to compliance with any applicable securities laws, the Company acknowledges

that the Holder may freely trade in any securities issued by the Company, may possess and use any information provided by the Company

in connection with such trading activity, and may disclose any such information to any third party.

12.

AMENDMENT AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either

retroactively or prospectively) only with the signed written consent of the Company and the Holder.

13.

GOVERNING LAW AND VENUE. Any action brought by either party against the other concerning the transactions contemplated by this

Warrant shall be brought only in the State of Delaware. This Warrant shall be construed and enforced in accordance with, and all questions

concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the

State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware

or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. For any

litigation arising in connection with this Warrant (and notwithstanding the terms (specifically including any governing law and venue

terms) of any transfer agent services agreement or other agreement between the Company’s transfer agent and the Company, such litigation

specifically includes, without limitation any action between or involving Company and the Company’s transfer agent with respect

to this Warrant in any way (specifically including, without limitation, any action where Company seeks to obtain an injunction, temporary

restraining order, or otherwise prohibit the Company’s transfer agent from issuing shares of Common Stock to Holder for any reason)),

each party hereto hereby (i) consents to and expressly submits to the exclusive personal jurisdiction of any state or federal court sitting

in the State of Delaware, (ii) expressly submits to the exclusive venue of any such court for the purposes hereof, (iii) agrees to not

bring any such action (specifically including, without limitation, any action where Company seeks to obtain an injunction, temporary

restraining order, or otherwise prohibit the Company’s transfer agent from issuing shares of Common Stock to Holder for any reason)

outside of any state or federal court sitting in the State of Delaware, and (iv) waives any claim of improper venue and any claim or

objection that such courts are an inconvenient forum or any other claim, defense or objection to the bringing of any such proceeding

in such jurisdiction or to any claim that such venue of the suit, action or proceeding is improper. Notwithstanding anything in the foregoing

to the contrary, nothing herein (i) shall limit, or shall be deemed or construed to limit, the ability of the Holder to realize on any

collateral or any other security, or to enforce a judgment or other court ruling in favor of the Holder, including through a legal action

in any court of competent jurisdiction, or (ii) shall limit, or shall be deemed or construed to limit, any provision of Section 15 of

this Warrant. The Company hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any objection to jurisdiction

and venue of any action instituted hereunder, any claim that it is not personally subject to the jurisdiction of any such court, and

any claim that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding

is improper (including but not limited to based upon forum non conveniens). THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT

IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT

OF THIS WARRANT OR ANY TRANSACTIONS CONTEMPLATED HEREBY. The Company irrevocably waives personal service of process and consents

to process being served in any suit, action or proceeding in connection with this Warrant or any other agreement, certificate, instrument

or document contemplated hereby or thereby by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence

of delivery) to the Company at the address in effect for notices to it under this Warrant and agrees that such service shall constitute

good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to

serve process in any other manner permitted by law. The prevailing party in any action or dispute brought in connection with this Warrant

or any other agreement, certificate, instrument or document contemplated hereby or thereby shall be entitled to recover from the other

party its reasonable attorney’s fees and costs. If any provision of this Warrant shall be invalid or unenforceable in any jurisdiction,

such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Warrant in that jurisdiction

or the validity or enforceability of any provision of this Warrant in any other jurisdiction.

14.

ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions

contained herein.

15.

DISPUTE RESOLUTION.

(a)

Submission to Dispute Resolution.

(i)

Notwithstanding anything to the contrary in this Warrant, in the case of a dispute relating to the Exercise Price, the Closing Sale Price,

the Closing Bid Price, or fair market value or the arithmetic calculation of the number of Warrant Shares (as the case may be) (including,

without limitation, a dispute relating to the determination of any of the foregoing) (the “Warrant Calculations”), the Company

or the Holder (as the case may be) shall submit the dispute to the other party via electronic mail (A) if by the Company, within two

(2) Trading Days after the occurrence of the circumstances giving rise to such dispute or (B) if by the Holder, at any time after the

Holder learned of the circumstances giving rise to such dispute. If the Holder and the Company are unable to agree upon such determination

or calculation within two (2) Trading Days following such initial notice by the Company or the Holder (as the case may be) of such dispute

to the Company or the Holder (as the case may be), then the Holder may, at its sole option, submit the dispute to an independent, reputable

investment bank or independent, outside accountant selected by the Holder (the “Independent Third Party”), and the Company

shall pay all expenses of such Independent Third Party.

(ii)

The Holder and the Company shall each deliver to such Independent Third Party (A) a copy of the initial dispute submission so delivered

in accordance with the first sentence of this Section 15(a) and (B) written documentation supporting its position with respect to such

dispute, in each case, no later than 5:00 p.m. (New York time) by second (2nd) Business Day immediately following the date on which the

Holder selected such Independent Third Party (the “Dispute Submission Deadline”) (the documents referred to in the immediately

preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute Documentation”) (it being understood

and agreed that if either the Holder or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute Submission

Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and hereby

waives its right to) deliver or submit any written documentation or other support to such Independent Third Party with respect to such

dispute and such Independent Third Party shall resolve such dispute based solely on the Required Dispute Documentation that was delivered

to such Independent Third Party prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company

and the Holder or otherwise requested by such Independent Third Party, neither the Company nor the Holder shall be entitled to deliver

or submit any written documentation or other support to such Independent Third Party in connection with such dispute, other than the

Required Dispute Documentation.

(iii)

The Company and the Holder shall cause such Independent Third Party to determine the resolution of such dispute and notify the Company

and the Holder of such resolution no later than five (5) Business Days immediately following the Dispute Submission Deadline. The fees

and expenses of such Independent Third Party shall be borne solely by the Company, and such Independent Third Party’s resolution

of such dispute shall be final and binding upon all parties absent manifest error.

(b)

Miscellaneous. The Company expressly acknowledges and agrees that (i) this Section 15 constitutes an agreement to arbitrate

between the Company and the Holder (and constitutes an arbitration agreement) under the rules then in effect under the Delaware Rules

of Civil Procedure (“DRCP”) and that the Holder is authorized to apply for an order to compel arbitration pursuant to the

DRCP in order to compel compliance with this Section 15, (ii) a dispute relating to the Warrant Calculations includes, without limitation,

disputes as to (A) whether an issuance or sale or deemed issuance or sale of Common Stock occurred under Section 2 of this Warrant, (B)

the consideration per share at which an issuance or deemed issuance of Common Stock occurred, and (C) whether any issuance or sale or

deemed issuance or sale of Common Stock was an issuance or sale or deemed issuance or sale, (iii) the terms of this Warrant and each

other applicable Transaction Document shall serve as the basis for the selected Independent Third Party’s resolution of the applicable

dispute, such Independent Third Party shall be entitled (and is hereby expressly authorized) to make all findings, determinations and

the like that such Independent Third Party determines are required to be made by such Independent Third Party in connection with its

resolution of such dispute (including, without limitation, determining (A) whether an issuance or sale or deemed issuance or sale of

Common Stock occurred under Section 2 of this Warrant, (B) the consideration per share at which an issuance or deemed issuance of Common

Stock occurred, and (C) whether any issuance or sale or deemed issuance or sale of Common Stock was an issuance or sale or deemed issuance

or sale, and in resolving such dispute such Independent Third Party shall apply such findings, determinations and the like to the terms

of this Warrant and any other applicable Transaction Documents, (iv) the Holder (and only the Holder), in its sole discretion, shall

have the right to submit any dispute described in this Section 15 to any other jurisdiction provided for in Section 13 of this Warrant

in lieu of utilizing the procedures set forth in this Section 15, and (v) nothing in this Section 15 shall limit the Holder from

obtaining any injunctive relief or other equitable remedies (including, without limitation, with respect to any matters described in

this Section 15).

16.

CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

(a)

“Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled

by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a

Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of

directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.

(b)

“Bloomberg” means Bloomberg, L.P.

(c)

“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in the State of Delaware

are authorized or required by law to remain closed; provided, however, for clarification,

commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,

“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations

at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial

banks in the State of Delaware generally are open for use by customers on such day.

(d)

“Change of Control” means any Fundamental Transaction other than (i) any merger of the Company or any of its, direct

or indirect, wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or reclassification

of the shares of Common Stock in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization

or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and,

directly or indirectly, are, in all material respects, the holders of the voting power of the surviving entity (or entities with the

authority or voting power to elect the members of the board of directors (or their equivalent if other than a corporation) of such

entity or entities) after such reorganization, recapitalization or reclassification, (iii) pursuant to a migratory merger effected solely

for the purpose of changing the jurisdiction of incorporation of the Company or any of its Subsidiaries or (iv) bone fide arm’s

length acquisitions by the Company with one or more third parties as long as holders of the Company’s voting power as of the Issuance

Date continue after such acquisition to hold publicly traded securities and, directly or indirectly, are, in all material respects, the

holders of at least 51% of the voting power of the surviving entity (or entities with the authority or voting power to elect the

members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such acquisition.

(e)

“Closing Bid Price” and “Closing Sale Price” means, for any security as of any date, (i) the last

closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Quotestream or

other similar quotation service provider designated by the Holder, or, if the Principal Market begins to operate on an extended hours

basis and does not designate the closing trade price, then the last trade price of such security prior to 4:00 p.m., New York time, as

reported by Quotestream or other similar quotation service provider designated by the Holder, or (ii) if the foregoing does not apply,

the last trade price of such security in the over-the-counter market for such security as reported by Quotestream or other similar quotation

service provider designated by the Holder, or (iii) if no last trade price is reported for such security by Quotestream or other similar

quotation service provider designated by the Holder, the average of the bid and ask prices of any market makers for such security as

reported by Quotestream or other similar quotation service provider designated by the Holder. If the Closing Sale Price cannot be calculated

for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the

fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair

market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 15. All such determinations

to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable

calculation period.

(f)

“Common Stock” means the common stock of the Company, $0.0001 par value per share, and any other class of securities

into which such securities may hereafter be reclassified or changed.

(g)

“Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at

any time Common Stock, including without limitation any debt, preferred stock, rights, options, warrants or other instrument that is

at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

(h)

[Intentionally Omitted].

(i)

“Eligible Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq

Global Market, Nasdaq Capital Market, or equivalent national securities exchange.

(j)

[Intentionally Omitted].

(k)

[Intentionally Omitted].

(l)

[Intentionally Omitted].

(m)

“Fundamental Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries,

Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the

surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all

of the properties or assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation

S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject

to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that

is accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of

Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject

Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock

such that all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or

exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding

shares of Common Stock, or (iv) consummate a stock or share purchase agreement or other business combination (including, without limitation,

a reorganization, recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities,

individually or in the aggregate, acquire, either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the

outstanding shares of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or

Affiliated with any Subject Entity making or party to, such stock purchase agreement or other business combination were not outstanding;

or (z) such number of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in

Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify

its Common Stock, (B) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one

or more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the “beneficial

owner” (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment,

conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination,

reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise

in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common

Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such

Subject Entities as of the date of this Warrant calculated as if any shares of Common Stock held by all such Subject Entities were not

outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock

or other equity securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other

transaction requiring other shareholders of the Company to surrender their shares of Common Stock without approval of the shareholders

of the Company or (C) directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions,

the issuance of or the entering into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the

intent of this definition in which case this definition shall be construed and implemented in a manner otherwise than in strict conformity

with the terms of this definition to the extent necessary to correct this definition or any portion of this definition which may be defective

or inconsistent with the intended treatment of such instrument or transaction.

(n)

“Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose

common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent

Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

(o)

“Person” and “Persons” means an individual, a limited liability company, a partnership, a joint

venture, a corporation, a trust, an unincorporated organization, any other entity and any governmental entity or any department or agency

thereof.

(p)

“Principal Market” shall mean any of the national exchanges (i.e. NYSE, NYSE American, and Nasdaq) which is at the

time the principal trading platform for the Common Stock (excluding all OTC marketplaces).

(q)

“Market Price” means the highest traded price of the Common Stock during the thirty (30) Trading Days prior to the

date of the respective Exercise Notice.

(r)

“Successor Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from

or surviving any Fundamental Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental

Transaction shall have been entered into.

(s)

“Trading Day” means any day on which the Common Stock is listed or quoted on its Principal Market, provided, however,

that if the Common Stock is not then listed or quoted on any Principal Market, then any calendar day.

* * * * * *

WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.

CHANGE

AGENTS CORPORATION

Name:

Sam Knipper

Title:

Chief Financial Officer

EXHIBIT

EXERCISE

NOTICE

(To

be executed by the registered holder to exercise this Common Stock Purchase Warrant)

THE

UNDERSIGNED holder hereby exercises the right to purchase of

the shares of Common Stock (“Warrant Shares”) of CHANGE AGENTS CORPORATION, a Delaware corporation (the “Company”),

evidenced by the attached copy of the Common Stock Purchase Warrant (the “Warrant”). Capitalized terms used herein and not

otherwise defined shall have the respective meanings set forth in the Warrant.

1. Form

of Exercise Price. The Holder intends that payment of the Exercise Price shall be made

as (check one):

☐ a

cash exercise with respect to

Warrant Shares; or

☐ by

cashless exercise pursuant to the Warrant.

2. Payment

of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable

Aggregate Exercise Price in the sum of $

to the Company in accordance with the terms of the Warrant.

3. Delivery

of Warrant Shares. The Company shall deliver to the holder

Warrant Shares in accordance with the terms of the Warrant.

Date:

(Print Name of Registered Holder)

By:

Name:

Title:

EX-4.2 — FORM OF UNSECURED PROMISSORY NOTE

EX-4.2

Filename: ea030873701ex4-2.htm · Sequence: 3

Exhibit 4.2

UNSECURED PROMISSORY NOTE

Principal Amount: [$150,000.00][$100,000.00]

Amount Due at Maturity: [$183,335.00][$116,665.00]

Date of Note: October 16, 2026

Maturity Date: December 1, 2026

FOR VALUE RECEIVED, Change Agents Corporation

of 4400 US Highway 9, Suite 3100, Freehold, NJ 07728 (the “Borrower”), hereby promises to pay to the order of ________ (the

“Lender”), the sums set forth below, on the terms and conditions stated in this unsecured Promissory Note (this “Note”).

1. PRINCIPAL AND REPAYMENT

Lender has advanced to Borrower the principal

sum of [One Hundred Fifty Thousand and 00/100 Dollars ($150,000.00)][One Hundred Thousand and 00/100 Dollars ($100,000.00)] (the “Principal”),

receipt of which Borrower acknowledges. Borrower shall repay to Lender the total sum of [One Hundred Eighty Three Thousand Three Hundred

and Thirty Five 00/100 Dollars ($183,335.00)][One Hundred Sixteen Thousand Six Hundred and Sixty Five 00/100 Dollars ($116,665.00)] (the

“Repayment Amount”) in a single payment of principal and all charges, due and payable in full on December 1, 2026 (the “Maturity

Date”). No installment payments are required prior to the Maturity Date.

2. MANNER OF PAYMENT

All payments under this Note shall be made in

lawful money of the United States by wire transfer of immediately available funds to an account designated in writing by Lender, or by

such other method as Lender may direct in writing. If the Maturity Date falls on a Saturday, Sunday, or federal holiday, payment shall

be due on the next succeeding business day.

3. PREPAYMENT

Borrower may prepay this Note in whole at any

time prior to the Maturity Date without penalty. Any prepayment shall be in the full Repayment Amount of $300,000.00, which amount is

fixed and shall not be reduced or discounted by reason of early payment.

4. EVENTS OF DEFAULT

Each of the following shall constitute an event

of default under this Note (each, an “Event of Default”): (a) Borrower’s failure to pay the Repayment Amount in full

on the Maturity Date; (b) any representation or warranty made by Borrower in this Note or in connection with the loan proving to have

been false or misleading in any material respect when made; (c) the filing by or against Borrower of any petition under the United States

Bankruptcy Code, or the appointment of a receiver for Borrower or the Property, which in the case of an involuntary filing is not dismissed

within sixty (60) days; or (e) the entry of any judgment against Borrower that remains unsatisfied or unstayed for thirty (30) days.

6. REMEDIES

Upon the occurrence of an Event of Default, the

entire Repayment Amount then outstanding shall become immediately due and payable without notice, presentment, or demand, and Lender may

exercise all rights and remedies available at law. From and after the Maturity Date or the occurrence of an Event of Default, whichever

is earlier, all amounts outstanding shall bear interest at the rate of sixteen percent (16%) per annum until paid in full.

7. COSTS OF COLLECTION

Borrower agrees to pay all reasonable costs and

expenses incurred by Lender in enforcing this Note or collecting any amounts due hereunder, including reasonable attorneys’ fees

and court costs, whether or not suit is commenced.

8. WAIVERS

Borrower and all endorsers, sureties, and guarantors

hereby waive presentment for payment, demand, protest, notice of protest, and notice of dishonor. No delay or omission by Lender in exercising

any right under this Note shall operate as a waiver of that right or of any other right.

9. GOVERNING LAW AND VENUE

This Note shall be governed by and construed in

accordance with the laws of the State of Delaware without regard to its conflict of laws principles. Borrower irrevocably consents to

the exclusive jurisdiction and venue of the state and federal courts located Delaware, for any action arising out of or relating to this

Note.

10. MISCELLANEOUS

This Note constitutes the entire agreement between

the parties with respect to its subject matter and supersedes all prior negotiations and understandings. This Note may not be amended

except by a written instrument signed by both parties. If any provision of this Note is held unenforceable, the remaining provisions shall

remain in full force and effect. This Note shall be binding upon Borrower and its successors and assigns and shall inure to the benefit

of Lender and Lender’s successors and assigns.

IN WITNESS WHEREOF, Borrower has executed this

unsecured Promissory Note as of the date first written above.

BORROWER:

Change Agents

Title: Chief Financial Officer

ACKNOWLEDGED AND AGREED — LENDER:

EX-10.1 — FORM OF OCTOBER 2026 WAIVER

EX-10.1

Filename: ea030873701ex10-1.htm · Sequence: 4

Exhibit

10.1

WAIVER

AGREEMENT

This

waiver agreement (this “Waiver”) is entered into as of October 4, 2026 (the “Effective Date”), by and between

Change Agents Corporation, a Delaware corporation (the “Company”), and [Dune Equity Holdings LLC][FirstFire Global Opportunities

Fund LLC], a Delaware limited liability company (the “Holder”). Reference is made to that certain promissory note, dated

as of June 1, 2026 (the “Note”), in the original principal amount of $250,000.00, issued by the Company to the Holder. Capitalized

terms used but not defined herein have the meanings given in the Note. The Company and the Holder agree as follows:

1. Limited Waiver; Warrants.

a. Subject

to the terms of this Waiver, the Holder hereby agrees to the following: (i) a one-time waiver

of its rights under Section 1.3 of the Note solely as it applies to (a) the promissory notes

in the original aggregate principal amount of $336,000.00, which were issued by the Company

to C/M Capital Master Fund, LP and WVP Emerging Manager Onshore Fund, LLC on or around September

30, 2026 (the “Notes”), as further described in the Company’s Form 8-K

filed on October 2, 2026, and (ii) a one-time waiver of the repayment from proceeds under

Section 1.4 of the Note solely with respect to the proceeds received by the Company pursuant

to the Notes.

b. In

consideration for the Holder’s execution of this Waiver, the Company shall issue to

the Holder a pre-funded warrant (the “Pre-Funded Warrant”) to purchase, 62,000

shares (the “Pre-Funded Warrant Shares”) of Common Stock (as defined below),

at an exercise price of $0.0001 per share, in the form attached hereto as Exhibit A. Notwithstanding

anything in this Agreement to the contrary, and in addition to the limitations set forth

herein, the Company shall not issue a number of Pre-Funded Warrant Shares, which when aggregated

with all other securities that are required to be aggregated for purposes of Nasdaq Listing

Rule 5635(d), would exceed 19.99% of the shares of Common Stock outstanding as of the date

of definitive agreement with respect to the first of such aggregated transactions, unless

the Company has obtained the Stockholder Approval (as defined below). “Common Stock”

shall mean the Company’s common stock, $0.0001 par value per share, and any shares

of any other class of common stock whether now or hereafter authorized, having the right

to participate in the distribution of dividends (as and when declared) and assets (upon liquidation

of the Company). If the Company proposes to file any registration statement covering any

of its securities (for sale by the Company, for resale by the holder(s) of such securities,

or otherwise, excluding any registration statement on Form S-8) (each a “Registration

Statement”), the Company shall at each such time give written notice to Holder of its

intention to do so (each a “Registration Notice”) at least seven (7) calendar

days prior to the filing of such Registration Statement and of the registration rights granted

under this Waiver. Upon the written request of Holder made to the Company within three (3)

calendar days after the receipt of any such Registration Notice, the Company shall, at its

sole cost and expense, effect the registration of all of the Pre-Funded Warrant Shares underlying

the Pre-Funded Warrant which the Company has been so requested to register by Holder in such

Registration Statement, by inclusion of such Pre-Funded Warrant Shares in the Registration

Statement, to the extent required to permit the Holder’s resale and disposition (in

accordance with the intended methods of disposition, including but not limited to sales at

prevailing market prices) of the Pre-Funded Warrant Shares.

c. “Stockholder

Approval” means such approval as may be required by the applicable rules and regulations

of the Nasdaq Stock Market LLC (or any successor entity) from the stockholders of the Company

with respect to the issuance of Common Stock under the Warrants (the “Exercise Shares”)

that, when taken together with any other securities that are required to be aggregated with

the issuance of the Exercise Shares for purposes of Nasdaq Listing Rule 5635(d), would exceed

19.99% of the issued and outstanding Common Stock as of the date of definitive agreement

with respect to the first of such aggregated transactions. The Company shall use reasonable

best efforts to obtain the Stockholder Approval at the first meeting of its shareholders

after the Effective Date.

Full Force and Effect. Except as expressly set forth herein, the Note remains in full force and effect and are hereby ratified and

confirmed.

Governing Law and Venue; Counterparts. Section 3.6 of the Note shall apply to this Waiver. This Waiver may be executed in counterparts

(including by electronic transmission), each of which shall be deemed an original and all of which together shall constitute one instrument.

[Signature

page to follow]

-1-

WITNESS WHEREOF, the parties have executed this Waiver as of the date first written above.

CHANGE AGENTS CORPORATION

By:

Name:

Sam Knipper

Title:

Chief Financial Officer

[DUNE EQUITY HOLDINGS LLC][FIRSTFIRE GLOBAL OPPORTUNITIES FUND LLC]

By:

Name:

Title

-2-

Exhibit

(see

attached)

-3-

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.3

Cover

Oct. 13, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Oct. 13, 2026

Entity File Number

001-38728

Entity Registrant Name

Change Agents Corporation

Entity Central Index Key

0001630212

Entity Tax Identification Number

47-1685128

Entity Incorporation, State or Country Code

Entity Address, Address Line One

4400 Route 9 South

Entity Address, Address Line Two

Suite 3100

Entity Address, City or Town

Freehold

Entity Address, State or Province

Entity Address, Postal Zip Code

07728

City Area Code

732

Local Phone Number

780-4400

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common stock, $0.0001 par value

Trading Symbol

CHGA

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration